Insufficiency of Positron Emission Tomography and Magnetic Resonance Spectroscopy in the Diagnosis of Intravascular Lymphoma of the Central Nervous System
Open Access
- 1 January 2012
- journal article
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 5 (2), 339-346
- https://doi.org/10.1159/000339963
Abstract
Intravascular large B-cell lymphoma (IVL) is a rare type of extranodal lymphoma with an aggressive clinical course characterized by the proliferation of lymphoma cells within the lumen of small vessels. Diagnosis is often difficult because of marked variability in clinical presentation and nonspecific laboratory and radiological findings, especially when central nervous system (CNS) symptoms are the only manifestation. Modern metabolic imaging techniques such as positron emission tomography (PET) and 1H-magnetic resonance spectroscopy (MRS) have been reported to be useful in the diagnosis of conventional primary CNS lymphoma. We report the case of a 69-year-old man who presented with a progressive leukoencephalopathic syndrome. The patient was examined by 18F-fluorodeoxyglucose and 11C-methionine PET and MRS, but none of these examinations were able to show the presence of a tumor in the lesions or to clarify the tumor characteristics. Brain biopsy was the only way to obtain a definite diagnosis of IVL. The patient was treated intensively with standard immunochemotherapy but died 6 months after the diagnosis. Here, we discuss the insufficiency of modern metabolic imaging techniques, including PET and MRS, and recommend a rapid decision of brain biopsy in the diagnosis of IVL only involving the CNS.Keywords
This publication has 14 references indexed in Scilit:
- Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findingsAnnals of Nuclear Medicine, 2010
- Presentation and management of intravascular large B-cell lymphomaThe Lancet Oncology, 2009
- Brain lymphoma: usefulness of the magnetic resonance spectroscopyJournal of Neuro-Oncology, 2007
- Intravascular large B-cell lymphoma presenting with neurological syndromes: clinicopathologic studyClinical Neuropathology, 2007
- Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopyNeuroscience Letters, 2003
- World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997Journal of Clinical Oncology, 1999
- 11 C-methionine PET for differential diagnosis of low-grade gliomasNeurology, 1998
- Cerebral MR imaging in intravascular lymphomatosis.1998
- Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain.RadioGraphics, 1994
- Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography.1992